Best Practices - From bench top to IND
- explore how to effectively set up your pre-clinical POC studies
- address pre-clinical safety requirements and issues
- give you an overview of the manufacturing standards required for Phase I studies
At the end of the session, you have a better understanding of the IND requirements as well as how to ensure that your studies provide adequate information for you to make informed decisions on the the design of your first clinical study.
SPEAKERS
Wendy Hill -Gap StrategiesValentia Lee Brotherton - Ashuren
Peter Pekos - Dalton Pharma
DATE | TIME | LOCATION
May 13, 20085:00PM - 7:00PM
MaRS Centre, CR-2
101 College St.
Toronto, ON
MORE INFORMATION
For more information about this event, please email our Events Coordinator at:events@marsdd.com
416-673-8100
Click here for more information about the Best Practices Event Series >>
WEBCAST
Click to watch the webcast and download the presentation
|
PRESENTATIONS
- Optimizing Preclinical Proof of Concept
- Preclinical Development Planning for Emerging Pharma and Biotech Firms
- Preparing an IND Application: CMC
- Best Practices: From Benchtop to IND
UPCOMING EVENTS
PAST EVENTS
- October 9, 2008
Best Practices: Is Your Business Model Creative? - June 3, 2008
MaRS Best Practices Series - Good Laboratory Practices - May 13, 2008
MaRS Best Practices Series - From bench top to IND - April 24, 2008
MaRS Best Practices Series - IP Strategies for Medical Devices - April 7, 2008
MaRS Best Practices Series - Doing Business with the National Institutes of Health (NIH): Opportunities for industry - March 29, 2008
MaRS Best Practices Series - How to Draft a Patent Application - March 20, 2008
MaRS Best Practices Series - IP Strategies for Therapeutics - February 28, 2008
MaRS Best Practices Series - IP Strategies for Diagnostics - February 23, 2008
MaRS Best Practices Series - How to Draft a Patent Application - December 12, 2007
MaRS Best Practices Series - Focus on CNS Pharma deals: How to pull in the money - May 23, 2007
MaRS Best Practices Series - Pre-Clinical development workshop - MaRS Best Practices Series - Asymmetric Communications: Building Momentum through Non-Traditional Marketing
- April 11, 2007
MaRS Best Practices Series - Intellectual Property and Valuation of Emerging Medical Therapeutics - November 21, 2006
MaRS Best Practices Series - Business, Science, Technology and You: Financing R&D through Canada’s SR&ED Program - November 9, 2006
MaRS Best Practices Series - Introduction to Systems Biology - September 14, 2006
MaRS Best Practices Series - From Bench to Headline: Translating science for the media - September 8, 2006
MaRS Besst Practices Series - The Power of Pictonics: Using visualizations to tell your technology story - July 12, 2006
MaRS Best Practices Series - Why commercializing a technology is really, really hard to do - May 17, 2006
MaRS Best Practices Series - So what? Who cares? Why you? - April 5, 2006
MaRS Best Practices Series - The move toward drug development - February 11, 2006
MaRS Best Practices Series - How To Draft a Patent Application - February 9, 2006
MaRS Best Practices Series - New Technologies for Accelerating Drug Development
